Redirected, Genetically-Engineered T Regulatory Cells And Their Use In Suppression Of Autoimmune And Inflammatory Disease

Patent No. EP2126054 (titled "Redirected, Genetically-Engineered T Regulatory Cells And Their Use In Suppression Of Autoimmune And Inflammatory Disease") was filed by Yeda Research on Jan 31, 2008. The application was issued on Jul 6, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2126054

YEDA RESEARCH
Application Number
EP08728776A
Filing Date
Jan 31, 2008
Status
Revoked
Mar 10, 2023
Publication Date
Jul 6, 2016